INCYTE CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
INCYTE CORPORATION (INCY) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 9.12 million shares as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2026-04-28
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 9.12M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 9.28M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 9.88M shares.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 8.54M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number |
|---|---|
| 2026-03-31 | 9.12M shares 10-Q · filed 2026-04-28 |
| 2025-12-31 | 9.28M shares 10-Q · filed 2026-04-28 |
| 2025-09-30 | 9.88M shares 10-Q · filed 2025-10-28 |
| 2025-06-30 | 8.54M shares 10-Q · filed 2025-07-29 |
| 2025-03-31 | 8.45M shares 10-Q · filed 2025-04-29 |
| 2024-12-31 | 8.66M shares 10-K · filed 2026-02-10 |
| 2024-09-30 | 8.68M shares 10-Q · filed 2024-10-29 |
| 2024-06-30 | 7.08M shares 10-Q · filed 2024-07-30 |
| 2024-03-31 | 7.14M shares 10-Q · filed 2024-04-30 |
| 2023-12-31 | 7.17M shares 10-K · filed 2025-02-10 |
| 2023-09-30 | 7.30M shares 10-Q · filed 2023-10-31 |
| 2023-06-30 | 5.70M shares 10-Q · filed 2023-08-01 |
| 2023-03-31 | 5.55M shares 10-Q · filed 2023-05-02 |
| 2022-12-31 | 5.19M shares 10-K · filed 2024-02-13 |
| 2022-09-30 | 5.23M shares 10-Q · filed 2022-11-01 |
| 2022-06-30 | 3.85M shares 10-Q · filed 2022-08-02 |
| 2022-03-31 | 4.06M shares 10-Q · filed 2022-05-03 |
| 2021-12-31 | 3.97M shares 10-K · filed 2023-02-07 |
| 2021-09-30 | 3.63M shares 10-Q · filed 2021-11-02 |
| 2021-06-30 | 3.12M shares 10-Q · filed 2021-08-03 |
| 2021-03-31 | 3.59M shares 10-Q · filed 2021-05-04 |
| 2020-12-31 | 3.28M shares 10-K · filed 2022-02-08 |
| 2020-09-30 | 3.17M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 2.72M shares 10-Q · filed 2020-08-04 |
| 2020-03-31 | 2.87M shares 10-Q · filed 2020-05-05 |
| 2019-12-31 | 2.60M shares 10-K · filed 2021-02-09 |
| 2019-09-30 | 2.68M shares 10-Q · filed 2019-10-29 |
| 2019-06-30 | 1.96M shares 10-Q · filed 2019-07-30 |
| 2018-12-31 | 2.04M shares 10-K · filed 2020-02-13 |
| 2017-12-31 | 1.18M shares 10-K · filed 2019-02-14 |
| 2016-12-31 | 1.25M shares 10-K · filed 2018-02-15 |
| 2015-12-31 | 565.57K shares 10-K · filed 2017-02-14 |
| 2014-12-31 | 398.48K shares 10-K · filed 2016-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |